top logo


header divider
  Hello unlogged user XML Sitemap
header divider
.in.na Registry
header divider
.ws.na Registry
header divider
.tv.na Registry
header divider
.mobi.na Registry
header divider
Link Directory
header divider
Namibian Domain Registrar Thursday, January 08, 2009  
header divider
top left
 Top News
top right
pixel
pixel
bottom leftpixelbottom right

top left
 News Topics
top right
pixel
pixel
bottom leftpixelbottom right

top left
 Main Menu
top right
pixel
pixel
bottom leftpixelbottom right

top left
 Online
top right
pixel
There are 1 unlogged user and 0 registered users online.

You can log-in or register for a user account here.
pixel
bottom leftpixelbottom right

 

SafariNow
top left
Articles: Schering Rejects Takeover Bid By Pharmaceuticals Giant Merck
top right
pixel
Posted by admin on Thursday, March 16, 2006 - 07:46 AM
pixel
pixel
PostNuke The supervisory board of German drug maker Schering has turned down a takeover bid by rival pharmaceuticals firm Merck even as Merck indicated it might be prepared to raise its offer.
The takeover would make Merck a leading drug maker in Europe
 
Following a special meeting of its supervisory board on Tuesday evening, Schering's managing director, Hubertus Erlen said the board had rejected Merck's takeover bid as inappropriate.
He added that he had the support of the board to use "all options" to continue to raise Schering's value independently.   Merck's laboratory in Darmstadt offers a peek into some cutting-edge technology
Merck, the world's oldest pharmaceuticals firm, said on Monday that it was offering 77.0 euros ($92) per share or 14.6 billion euros overall to buy Schering, a world leader in contraceptives and fertility drugs, in a bid to become one of the leading drug makers in Europe.   Berlin-based Schering promptly turned down the advances of the 338-year-old family-run Merck, saying the offer price "significantly undervalues" its business.   Merck adopts wait-and-see approach   Merck indicated that it was not ruling out raising its bid. The company would first wait and see whether a rival offer materialized from a third party, Merck's supervisory board chief Wilhelm Simson told a news conference in Berlin.   But Merck was not prepared to pay so high a price that a purchase could only be financed by selling off bits of Schering, Simson added. The price of 77 euros per share was "fair", he continued. And Simson said he hoped to meet with Schering's chairman Hubertus Erlen later on Tuesday.   "Our main aim is to enter into negotiations with Schering," he said. "We need both sides to come to the table."   Berlin mayor frets over implications   Berlin mayor Wowereit is worried about the takeover plans
In the meantime, Berlin's Mayor Klaus Wowereit said he was "concerned" about Merck's plans to buy Schering, which is one of the biggest employers in the German capital.   After meeting with Merck chairman Roemer, Wowereit, a member of the Social Democratic Party (SPD), said he was worried about the fate of Schering's 6,000 employees in Berlin.   Schering is the only DAX-listed company that has its headquarters in Berlin and is one of the biggest employers in the German capital after rail operator Deutsche Bahn.   Berlin is home to very little industry and suffers from very high unemployment.   Suggestions last year that rail operator Deutsche Bahn could relocate some of its administrative activities to Hamburg sparked political uproar, eventually persuading the company to back down and remain in Berlin.       
DW staff / AFP (sp)
pixel
bottom left
Printer-friendly page · 97 Reads · Send this story to someone
bottom right

 
header divider
 
header divider
Namibia Internet Gateway cc
Copyright 2007
Google
 
. - . - . - . - . - . - . - . - . - . - . - .  - . - . - . - . - . -  . - . -  . - . - . - .